在不拔除导管的情况下通过暂时停止腹膜透析治疗复发性和耐药性连续性非卧床腹膜透析（CAPD）腹膜炎。
Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.
作者信息
Locatelli A, Quiroga M A, De Benedetti L, Gomez M, Barone R, Barron M C
机构信息
Servicio de Nefrologia Olivos, Buenos Aires, Argentina.
出版信息
Adv Perit Dial. 1995;11:176-8.
Recurrent and resistant continuous ambulatory peritoneal dialysis (CAPD) peritonitis is usually treated by removal of the catheter and temporary hemodialysis. We treated 3 patients: 1 with resistant Klebsiella peritonitis and 2 with recurrent peritonitis (one due to Staphylococcus and the other to Enterococcus), by stopping CAPD for a 2-4 week period, leaving the catheter in situ and continuing antibiotic therapy. All 3 patients had resolution of their infections and restarted CAPD. This therapeutic modality reduced catheter replacements, limited admissions to the hospital, reduced psychological impact, and diminished risks and costs of CAPD.
复发性和耐药性持续性非卧床腹膜透析（CAPD）腹膜炎通常通过拔除导管和临时血液透析进行治疗。我们治疗了3例患者：1例为耐药性克雷伯菌腹膜炎，2例为复发性腹膜炎（1例由葡萄球菌引起，另1例由肠球菌引起），方法是停止CAPD 2 - 4周，保留导管原位并继续抗生素治疗。所有3例患者的感染均得到缓解，并重新开始了CAPD。这种治疗方式减少了导管更换次数，减少了住院次数，减轻了心理影响，并降低了CAPD的风险和成本。
Zotero 插件